메뉴 건너뛰기
Clinical Trials
Volumn 7, Issue 1_suppl, 2010, Pages S56-S64
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: Efforts to harmonize procedures among the laboratories
Author keywords

[No Author keywords available]
Indexed keywords

ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INTRACELLULAR PORTION OF PROTEIN TYROSINE PHOSPHATASE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; REAGENT; UNCLASSIFIED DRUG; ANTIBODY; AUTOANTIGEN;
EID: 79952279727     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774510373496     Document Type: Article
Times cited : (24)
References (11)
  • 1
    • 0025039679 scopus 로고
    • Identification of the 64K autoantigen in insulin-dependent diabetes as GABA-synthesizing enzyme glutamic acid decarboxylase
    • Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (London) 1990; 347: 151-56
    • (1990) Nature (London) , vol.347 , pp. 151-156
    • Baekkeskov, S.1    Aanstoot, H.J.2    Christgau, S.3
  • 2
    • 0028351531 scopus 로고
    • Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
    • Rabin DU, Pleasic SM, Shapiro JA, et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994; 152: 3183-88
    • (1994) J Immunol , vol.152 , pp. 3183-3188
    • Rabin, D.U.1    Pleasic, S.M.2    Shapiro, J.A.3
  • 3
    • 0027930455 scopus 로고
    • Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
    • Lan SM, Lu J, Goto Y, Notkins AJ. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 13: 505-14
    • (1994) DNA Cell Biol , vol.13 , pp. 505-514
    • Lan, S.M.1    Lu, J.2    Goto, Y.3    Notkins, A.J.4
  • 4
    • 0029120042 scopus 로고
    • Relationship of the 37,000- and the 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
    • Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and the 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995; 96: 1506-11
    • (1995) J Clin Invest , vol.96 , pp. 1506-1511
    • Ma, P.1    Hawkes, C.J.2    Christie, M.R.3
  • 5
    • 0029040544 scopus 로고
    • Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity
    • Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-22
    • (1995) Diabetologia , vol.38 , pp. 816-822
    • Bonifacio, E.1    Genovese, S.2    Braghi, S.3
  • 6
    • 0037408360 scopus 로고    scopus 로고
    • Diabetes Antibody Standardization Program: First assay proficiency evaluation
    • Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003; 52: 1128-36
    • (2003) Diabetes , vol.52 , pp. 1128-1136
    • Bingley, P.J.1    Bonifacio, E.2    Mueller, P.W.3
  • 7
    • 41849115906 scopus 로고    scopus 로고
    • Diabetes Antibody Standardization Program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2
    • Torn C, Mueller PW, Schlosser M, et al. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008; 51: 846-52
    • (2008) Diabetologia , vol.51 , pp. 846-852
    • Torn, C.1    Mueller, P.W.2    Schlosser, M.3
  • 8
    • 0031738116 scopus 로고    scopus 로고
    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
    • Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998; 47: 1857-66
    • (1998) Diabetes , vol.47 , pp. 1857-1866
    • Verge, C.F.1    Stenger, D.2    Bonifacio, E.3
  • 9
    • 0030695027 scopus 로고    scopus 로고
    • Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
    • Bingley PJ, Bonifacio E, Williams AJ, et al. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-10
    • (1997) Diabetes , vol.46 , pp. 1701-1710
    • Bingley, P.J.1    Bonifacio, E.2    Williams, A.J.3
  • 10
    • 0032551674 scopus 로고    scopus 로고
    • The Melbourne Pre-Diabetes Study: Prediction of type 1 diabetes mellitus using antibody and metabolic testing
    • Colman PG, McNair P, Margetts H, et al. The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med J Aust 1998; 169: 81-84
    • (1998) Med J Aust , vol.169 , pp. 81-84
    • Colman, P.G.1    McNair, P.2    Margetts, H.3
  • 11
    • 0033782496 scopus 로고    scopus 로고
    • Participants of the study
    • The World Health Organization International Collaborative Study for islet cell antibodies
    • Mire-Sluis AR, Gaines Das R, Lernmark A. Participants of the study. The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 2000; 43: 1282-92
    • (2000) Diabetologia , vol.43 , pp. 1282-1292
    • Mire-Sluis, A.R.1    Gaines Das, R.2    Lernmark, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.